An investigation into human papillomavirus (HPV) vaccination for patients undergoing surgery for high-grade cervical or vulvar dysplasia

INTRODUCTION: Eligibility for the human papillomavirus (HPV) vaccine now includes adults 27 through 45 years. It has not been reported how providers are addressing HPV vaccination in patients with existing preinvasive disease. Our objectives were to determine the rates at which vaccination is offere...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyles, Glenn P., Baek, Jae, Pandit, Radhika, Cosgrove, Casey M., Bixel, Kristin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120215/
https://www.ncbi.nlm.nih.gov/pubmed/35603128
http://dx.doi.org/10.1016/j.gore.2022.101001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120215/
https://www.ncbi.nlm.nih.gov/pubmed/35603128
http://dx.doi.org/10.1016/j.gore.2022.101001

Ejemplares similares